Label: DENTA 5000 PLUS- sodium fluoride gel, dentifrice

  • NDC Code(s): 64980-305-50, 64980-306-50
  • Packager: Rising Pharmaceuticals, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

Drug Label Information

Updated 07/12

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    DENTA 5000 PLUS BRAND OF 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM

    Close
  • DESCRIPTION:

    Self-topical neutral fluoride dentifrice containing 1.1% (w/w) sodium fluoride for use as a dental caries preventative in adults and pediatric patients.

    Close
  • Active Ingredient:

    Sodium Fluoride 1.1% (w/w)

    Close
  • Inactive Ingredients:

    Water, Sorbitol, Hydrated Silica, Glycerin, Tetrapotassium Pyrophosphate, Flavor, PEG 12, Sodium Lauryl Sulfate, Carboxymethylcellulose Gum, Sodium Saccharin, Titanium Dioxide, FD&C Blue #1

    Close
  • CLINICAL PHARMACOLOGY:

    Frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into tooth enamel.

    Close
  • INDICATIONS AND USAGE:

    A dental caries preventive; for once daily self-applied topical use. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4 Denta 5000 Plus brand of 1.1% sodium fluoride in a squeeze-tube is easily applied onto a toothbrush. This prescription dental cream should be used once daily in place of your regular toothpaste unless otherwise instructed by your dental professional. May be used in areas where drinking water is fluoridated, since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)

    Close
  • CONTRAINDICATIONS:

    Do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.

    Close
  • WARNINGS:

    Prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under age 6 years, especially if the water fluoridation exceeds 0.6 ppm, since younger pediatric patients frequently can not perform the brushing process without significant swallowing. Use in pediatric patients under age 6 years requires special supervision to prevent repeated swallowing of the dental cream, which could cause dental fluorosis. Read directions carefully before using. Keep out of reach of infants and children.

    Close
  • PRECAUTIONS:

    Not for systemic treatment. DO NOT SWALLOW.

    Close
  • Carcinogenesis, Mutagenesis, Impairment of Fertility:

    In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer.

    Fluoride ion is not mutagenic in standard bacterial systems. It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. In vivo data are conflicting. Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results. Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.

    Close
  • Pregnancy: Category B.

    It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. Epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in childhood.

    Close
  • Nursing Mothers:

    It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.

    Close
  • Pediatric Use:

    The use of Denta 5000 Plus in pediatric age groups 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11 to 14 years conducted by Englander et al. 2,3, 4. Safety and effectiveness in pediatric patients below the age of 6 years have not been established. Please refer to the CONTRAINDICATIONS and WARNINGS sections.

    Close
  • ADVERSE REACTIONS:

    Allergic reactions and other idiosyncrasies have been rarely reported.

    Close
  • OVERDOSAGE:

    Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (i.e., less than 2.3 mg fluoride/lb body weight) have been ingested, give calcium (e.g., milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (i.e., more than 2.3 mg fluoride/lb body weight) have been ingested, induce emesis, give orally soluble calcium (e.g., milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e., more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility.

    A treatment dose (a thin ribbon) of Denta 5000 Plus contains 2.5 mg fluoride. A 1.8 oz. tube contains 255 mg fluoride.

    Close
  • DOSAGE AND ADMINISTRATION:

    Follow these instructions unless otherwise instructed by your dental professional:

    1. Adults and pediatric patients 6 years of age or older, apply a thin ribbon of Denta 5000 Plus to a toothbrush. Brush thoroughly once daily for two minutes, preferably at bedtime.
    2. After use, adults expectorate. For best results, do not eat, drink, or rinse for 30 minutes. Pediatric patients, ages 6-16, expectorate after use and rinse mouth thoroughly.
    Close
  • HOW SUPPLIED

    HOW SUPPLIED Spearment
    1.8 oz. (51g) net wt. tube NDC# 64980-305-50.

    STORAGE:

    Store at Controlled Room Temperature, 20-25°C (68-77°F)

    Close
  • SPL UNCLASSIFIED SECTION

    Rx only

    Close
  • REFERENCES:

    1. Accepted Dental Therapeutics, Ed. 40, ADA, Chicago. P. 405-407, 1984.
    2. Englander HR, Keyes et al: JADA 75:638-644, 1967.
    3. Englander HR, et al: JADA 78:783-787, 1969.
    4. Englander HR, et al: JADA 83:354-358, 1971.
    Close
  • SPL UNCLASSIFIED SECTION

    Manufactured by: Sheffield Laboratories Manufactured for: Rising Pharmaceuticals, Inc.
    New London, CT 06320 Allendale, NJ 07401

    Revision Date: 05/12

    Close
  • PRINCIPAL DISPLAY PANEL - 51 g Tube

    NDC 64980-305-50

    Rising

    Spearment

    Denta 5000 Plus

    1.1% SODIUM FLUORIDE Prescription Dental Cream

    5000 ppm Fluoride Plus Mild Cleaning System

    Rx ONLY

    NET WT. 1.8 OZ. (51 g)

    Principle Display Panel - 51 g Tube

    PRINCIPAL DISPLAY PANEL - 51 g Tube

    NDC 64980-306-50

    Rising

    2-PACK
    2x 1.8 OZ.
    BOXES

    Denta 5000 Plus

    1.1% SODIUM FLUORIDE Prescription Dental Cream

    5000 ppm Fluoride Plus Mild Cleaning System

    SPEARMINT

    Rx ONLY

    NET WT. 1.8 OZ. (51 g)

    Principle Display Panel - 51 g Tube
    Close
  • INGREDIENTS AND APPEARANCE
    DENTA 5000 PLUS 
    sodium fluoride gel, dentifrice
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:64980-305
    Route of Administration ORAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SODIUM FLUORIDE (FLUORIDE ION) SODIUM FLUORIDE 1.1 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    WATER  
    SORBITOL  
    HYDRATED SILICA  
    GLYCERIN  
    POTASSIUM PYROPHOSPHATE  
    POLYETHYLENE GLYCOL 600  
    SODIUM LAURYL SULFATE  
    CARBOXYMETHYLCELLULOSE  
    SACCHARIN SODIUM DIHYDRATE  
    TITANIUM DIOXIDE  
    FD&C BLUE NO. 1  
    Product Characteristics
    Color BLUE Score     
    Shape Size
    Flavor SPEARMINT Imprint Code
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:64980-305-50 51 g in 1 TUBE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    Unapproved drug other 07/13/2012
    DENTA 5000 PLUS 
    sodium fluoride gel, dentifrice
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:64980-306
    Route of Administration ORAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SODIUM FLUORIDE (FLUORIDE ION) SODIUM FLUORIDE 1.1 g  in 100 g
    Inactive Ingredients
    Ingredient Name Strength
    WATER  
    SORBITOL  
    HYDRATED SILICA  
    GLYCERIN  
    POTASSIUM PYROPHOSPHATE  
    POLYETHYLENE GLYCOL 600  
    SODIUM LAURYL SULFATE  
    CARBOXYMETHYLCELLULOSE  
    SACCHARIN SODIUM DIHYDRATE  
    TITANIUM DIOXIDE  
    FD&C BLUE NO. 1  
    Product Characteristics
    Color BLUE Score     
    Shape Size
    Flavor SPEARMINT Imprint Code
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:64980-306-50 2 in 1 CARTON
    1 51 g in 1 TUBE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    Unapproved drug other 07/13/2012
    Labeler - Rising Pharmaceuticals, Inc. (041241766)
    Registrant - Rising Pharmaceuticals, Inc. (041241766)
    Establishment
    Name Address ID/FEI Business Operations
    Sheffield Pharmaceuticals Div of Faria Limited LLC 151177797 MANUFACTURE(64980-305, 64980-306)
    Establishment
    Name Address ID/FEI Business Operations
    Nutra-Med Packaging, Inc. 022004902 REPACK(64980-306)
    Close